Please login to the form below

Not currently logged in
Email:
Password:

Arix Biosciences

This page shows the latest Arix Biosciences news and features for those working in and with pharma, biotech and healthcare.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech. US biotech Imara has just closed a $63m series B financing round to further develop therapeutics for the treatment of blood disorders. ... In return, Arix owns 10% of the company and Investment Director

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Roche CEO and chairman joins Arix Bioscience Former Roche CEO and chairman joins Arix Bioscience

    Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature. ... His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics